Pacira BioSciences, Inc.
PCRX· Nasdaq
Released Mar 1, 2017, during market hours
10-K filed Mar 1, 2017, 60 days after period end · 0001396814-17-000009
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 |
|---|---|---|---|---|
| Revenue | $72.90M | $69.32M | $197.67M | $33.56M |
| Net Income | -$3.97M | -$2.50M | -$13.72M | -$11.96M |
| EPS Diluted | -$0.11 |
Pacira BioSciences, Inc. · CIK 1396814 · Engraved from SEC EDGAR
| -$0.07 |
| -$0.39 |
| -$0.36 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.